Identification of Genetic Alterations ofAXIN2Gene in Adrenocortical Tumors
Author(s) -
Audrey Chapman,
Julien Durand,
Lydia Ouadi,
Isabelle Bourdeau
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2010-2987
Subject(s) - axin2 , wnt signaling pathway , adrenocortical carcinoma , biology , gene , catenin , cancer research , somatic cell , identification (biology) , mutation , genetics , endocrinology , botany
Mutations of the β-catenin gene (CTNNB1), which lead to constitutive activation of Wnt signaling, have recently been described in adrenocortical adenomas (AA) and carcinomas (ACC). However, somatic CTNNB1 mutations may explain only about 50% of β-catenin accumulation observed in adrenocortical tumors, indicating that other components of the Wnt pathway may be involved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom